necessary for a fair presentation of the financial statements.
the sale of custom products or research and development contracts with third parties.
right to payment for performance completed to date.
a period of time using costs incurred as the measurement of progress towards completion.
the performance obligation by transferring goods or services.
and contract research and development contracts are satisfied in one year or less.
narrow amendments to clarify how to apply certain aspects of the new lease standard.
Currently our only lease is the lease for our facility.
of leased liabilities and a right-of-use asset of $261,644 as of April 1, 2019.
The leased liabilities and right-of-use asset exclude non-lease components.
which clarifies codification and corrects unintended application of the guidance.
at amortized cost basis to be presented at the net amount expected to be collected.
Net income per diluted share amounts assume exercise of all stock options.
as available-for-sale securities and carried at estimated fair value.
including money market funds, to be cash equivalents.
prescribe required disclosures about fair-value measurements.